153 related articles for article (PubMed ID: 29611450)
1. Elevated serum vascular endothelial growth factor in treatment-resistant schizophrenia treated with electroconvulsive therapy: Positive association with therapeutic effects.
Xiao W; Zhan Q; Ye F; Tang X; Li J; Dong H; Sha W; Zhang X
World J Biol Psychiatry; 2019 Feb; 20(2):150-158. PubMed ID: 29611450
[TBL] [Abstract][Full Text] [Related]
2. Nerve growth factor serum levels in treatment-resistant schizophrenic patients following electroconvulsive therapy.
Pacitti F; Bersani G; Aloe L; Caredda M; Orsi P; Quartini A; Vitali M; Ceccanti M; Tirassa P; Fiore M; Iannitelli A
Clin Ter; 2021; 171(1):e67-e74. PubMed ID: 33346332
[TBL] [Abstract][Full Text] [Related]
3. Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients.
Minelli A; Zanardini R; Abate M; Bortolomasi M; Gennarelli M; Bocchio-Chiavetto L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1322-5. PubMed ID: 21570438
[TBL] [Abstract][Full Text] [Related]
4. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
[TBL] [Abstract][Full Text] [Related]
5. Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.
Minelli A; Maffioletti E; Bortolomasi M; Conca A; Zanardini R; Rillosi L; Abate M; Giacopuzzi M; Maina G; Gennarelli M; Bocchio-Chiavetto L
Acta Psychiatr Scand; 2014 Jun; 129(6):461-6. PubMed ID: 23957507
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy.
Ryan KM; McLoughlin DM
Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):839-848. PubMed ID: 29968119
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms.
Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
Psychiatry Res; 2014 Dec; 220(1-2):175-80. PubMed ID: 25129562
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Electroconvulsive Therapy Augmentation of Antipsychotic Treatment on Cognitive Functions in Patients With Treatment-Resistant Schizophrenia.
Vuksan Ćusa B; Klepac N; Jakšić N; Bradaš Z; Božičević M; Palac N; Šagud M
J ECT; 2018 Mar; 34(1):31-34. PubMed ID: 29053485
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of antipsychotics with electroconvulsive therapy in treatment-resistant schizophrenia patients with dominant negative symptoms: a pilot study of effectiveness.
Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
Neuropsychobiology; 2014; 70(3):158-64. PubMed ID: 25358377
[TBL] [Abstract][Full Text] [Related]
10. A Pilot Study on Daily Intensive ECT over 8 Days Improved Positive and Negative Symptoms and General Psychopathology of Patients with Treatment-Resistant Schizophrenia up to 4 Weeks after Treatment.
Davarinejad O; Hendesi K; Shahi H; Brand S; Khazaie H
Neuropsychobiology; 2019; 77(2):83-91. PubMed ID: 30463074
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
Tang WK; Ungvari GS
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
[TBL] [Abstract][Full Text] [Related]
12. Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder.
Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
Brain Behav; 2021 Aug; 11(8):e02001. PubMed ID: 34342142
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
Grover S; Chakrabarti S; Hazari N; Avasthi A
Psychiatry Res; 2017 Mar; 249():349-353. PubMed ID: 28152470
[TBL] [Abstract][Full Text] [Related]
15. Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia.
Xiao W; Zhan Q; Ye F; Tang X; Li J; Dong H; Sha W; Zhang X
Eur Neuropsychopharmacol; 2018 May; 28(5):603-609. PubMed ID: 29602597
[TBL] [Abstract][Full Text] [Related]
16. Altered serum levels of vascular endothelial growth factor in first-episode drug-naïve and chronic medicated schizophrenia.
Ye F; Zhan Q; Xiao W; Tang X; Li J; Dong H; Sha W; Zhang X
Psychiatry Res; 2018 Jun; 264():361-365. PubMed ID: 29677618
[TBL] [Abstract][Full Text] [Related]
17. Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy-A pilot study.
Kranaster L; Blennow K; Zetterberg H; Sartorius A
J Affect Disord; 2019 Jun; 253():449-453. PubMed ID: 31103810
[TBL] [Abstract][Full Text] [Related]
18. Blood serum concentrations of kynurenic acid in patients diagnosed with recurrent depressive disorder, depression in bipolar disorder, and schizoaffective disorder treated with electroconvulsive therapy.
Olajossy M; Olajossy B; Wnuk S; Potembska E; Urbańska E
Psychiatr Pol; 2017 Jun; 51(3):455-468. PubMed ID: 28866716
[TBL] [Abstract][Full Text] [Related]
19. Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment.
Lee BH; Hong JP; Hwang JA; Ham BJ; Na KS; Kim WJ; Trigo J; Kim YK
Psychiatry Res; 2015 Jul; 228(1):95-9. PubMed ID: 25977072
[TBL] [Abstract][Full Text] [Related]
20. Effects of Electroconvulsive Therapy on Some Inflammatory Factors in Patients With Treatment-Resistant Schizophrenia.
Kartalci S; Karabulut AB; Erbay LG; Acar C
J ECT; 2016 Sep; 32(3):174-9. PubMed ID: 26886746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
